ICD-10 Coding for Neuropathy due to Chemotherapy(G62.0, T45.1x5*)
Complete ICD-10-CM coding and documentation guide for Neuropathy due to Chemotherapy. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Neuropathy due to Chemotherapy
G60-G64Primary Range
Polyneuropathies and other disorders of the peripheral nervous system
This range includes codes for neuropathies, including drug-induced polyneuropathy.
Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
This range includes codes for adverse effects of drugs, including chemotherapy agents.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| G62.0 | Drug-induced polyneuropathy | Use when neuropathy is directly linked to chemotherapy treatment. |
|
| T45.1x5* | Adverse effect of antineoplastic and immunosuppressive drugs | Use as a secondary code to specify the adverse effect of chemotherapy. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for neuropathy due to chemotherapy
Essential facts and insights about Neuropathy due to Chemotherapy
Primary ICD-10-CM Codes for neuropathy due to chemotherapy
Decision Criteria
clinical Criteria
- Neuropathy symptoms directly linked to chemotherapy agents
documentation Criteria
- Detailed history and examination excluding other causes
Applicable To
- Polyneuropathy due to chemotherapy
Excludes
- Polyneuropathy in diabetes (E11.42)
Clinical Validation Requirements
- Explicit documentation linking neuropathy to chemotherapy
- Exclusion of other causes such as diabetes or vitamin deficiencies
Code-Specific Risks
- Misclassification if not explicitly linked to chemotherapy
Coding Notes
- Ensure documentation explicitly links neuropathy to chemotherapy.
T45.1x5* - Adverse effect of antineoplastic and immunosuppressive drugs
Use as a secondary code to specify the adverse effect of chemotherapy.
Applicable To
- Adverse effects of chemotherapy drugs
Clinical Validation Requirements
- Documentation of adverse effects related to chemotherapy
Coding Notes
Ensure correct sequencing with G62.0 as primary.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Polyneuropathy in diabetes
G63.4Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Neuropathy due to Chemotherapy to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code G62.0.
Impact
Clinical: Inaccurate diagnosis and treatment planning, Regulatory: Non-compliance with documentation standards, Financial: Potential claim denials or reduced reimbursement
Mitigation Strategy
Educate providers on documentation standards, Use templates to ensure comprehensive notes
Impact
Reimbursement: Potential underpayment due to incorrect coding, Compliance: Non-compliance with coding guidelines, Data Quality: Inaccurate clinical data representation
Mitigation Strategy
Query provider to confirm neuropathy is treatment-related.
Impact
G62.0 must be primary with T45.1x5* as secondary.
Mitigation Strategy
Regular training on coding guidelines and sequencing rules.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Neuropathy due to Chemotherapy, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Neuropathy due to Chemotherapy
Use these documentation templates to ensure complete and accurate documentation for Neuropathy due to Chemotherapy. These templates include all required elements for proper coding and billing.
Oncology progress note for CIPN
Specialty: OncologyRequired Elements
- Chemotherapy agent and dose
- Symptom onset and distribution
- Functional impact assessment
- Exclusion of other causes
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Neuropathy due to Chemotherapy? Ask your questions below.